Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-150%Return on Invested Capital
VS
Market
Sector
Industry
History
$ 0.68Close
$ 0.43 - $ 2.87 52-Week Range
Ticker Information
Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSANGAMO THERAPEUTICS INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SGMO - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 43.06M | $ -64.59M | -150% |
| 3/31/2025 | $ 29.78M | $ -80.74M | -271.09% |
| 12/31/2024 | $ 49.02M | $ -97.94M | -199.79% |
| 9/30/2024 | $ 66.86M | $ -136.13M | -203.6% |
| 6/30/2024 | $ 52.79M | $ -249.68M | -472.99% |
| 3/31/2024 | $ 87.51M | $ -328.05M | -374.86% |
| 12/31/2023 | $ 116.4M | $ -257.83M | -221.5% |
| 9/30/2023 | $ 169.9M | $ -249.51M | -146.86% |
| 6/30/2023 | $ 270.01M | $ -198.5M | -73.51% |
| 3/31/2023 | $ 373.31M | $ -127.17M | -34.06% |
Key Performance Insights, Last 5 Years
- SANGAMO THERAPEUTICS INC's latest trailing twelve months (TTM) ROIC stands at -13.55%.
- Over the past 5 years, SANGAMO THERAPEUTICS INC's average ROIC has been -126.17%.
- The median ROIC for SANGAMO THERAPEUTICS INC during this period was -54.27%
- SANGAMO THERAPEUTICS INC reached its highest ROIC over the past 5 years at -13.55%.
- The lowest ROIC recorded by SANGAMO THERAPEUTICS INC in the same timeframe -472.99%
SANGAMO THERAPEUTICS INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for SANGAMO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -75.84M ] / Inv. Capital [ $ 559.67M ]
(=) ROIC [ -13.55% ] SGMO - Return on Invested Capital, Last 5 years
-472.99%
Minimum
Jun 30, 2024
-13.55%
Maximum
Sep 30, 2020
-126.17%
Average
-54.27%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.69% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.69% |
| median | 3.38% |
| std | 15.18% |